1.
Bone Marrow Transplant
; 33(9): 921-3, 2004 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15034544
RESUMO
Rituximab, an anti-CD20 monoclonal antibody, is increasingly used in the treatment of B-cell non-Hodgkin's lymphoma. Late-onset neutropenia in relation to rituximab has been recently described. In this report, we present six cases occurring after stem cell transplantation and discuss the potential impact of this complication.